Pacific Biosciences Of California (PACB) EPS (Basic) Growth (3y) (2013 - 2026)
Pacific Biosciences Of California (PACB) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 17.98% |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | 19.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.81% |
| Mar 31, 2026 | 57.94% |
| Dec 31, 2025 | 28.98% |
| Sep 30, 2025 | 28.25% |
| Jun 30, 2025 | 23.98% |
| Mar 31, 2025 | -57.60% |
| Dec 31, 2024 | 26.52% |
| Jun 30, 2024 | -12.73% |
| Mar 31, 2024 | -14.09% |
| Dec 31, 2023 | -39.47% |
| Sep 30, 2023 | 87.73% |
| Jun 30, 2023 | 91.91% |
| Mar 31, 2023 | -18.38% |
| Dec 31, 2022 | -43.46% |
| Sep 30, 2022 | -22.04% |
| Jun 30, 2022 | -24.75% |
| Mar 31, 2022 | -20.20% |
| Dec 31, 2021 | -13.66% |
| Jun 30, 2021 | -26.07% |
| Mar 31, 2021 | 27.41% |